Table 1.
Demographics, characteristics, and peripheral neurological complication
| Total patients (14) | Peripheral neurological complication |
|||
|---|---|---|---|---|
| Plexopathy (n = 4) | Peripheral neuropathy (n = 6) | Entrapment neuropathy (n = 10) | ||
| Median age, range (years) | 57, 33–82 | 54, 43–66 | 51, 33–71 | 56, 33–82 |
| Male no. (%) | 14 (100) | 4 (100) | 6 (100) | 9 (100) |
| White no. (%) | 6 (43) | 1 (25) | 4 (67) | 3 (33) |
| Hispanic/Latino no. (%) | 6 (43) | 3 (75) | 2 (33) | 4 (44) |
| Asian no. (%) | 2 (14) | 0 (0) | 0 (0) | 2 (22) |
| COVID-19 status no. (%) | 13 (93) | 4 (100) | 5 (83) | 9 (100) |
| Diabetes mellitus no. (%) | 6 (43) | 1 (25) | 1 (17) | 6 (67) |
| Obesity no. (%) | 4 (29) | 1 (25) | 1 (17) | 4 (44) |
| Intubation for COVID-19 no. (%) | 14 (100) | 4 (100) | 6 (100) | 9 (100) |
| Paralysis during hospitalization no. (%) | 6 (43) | 2 (50) | 4 (67) | 3 (33) |
| Pronation for ARDS no. (%) | 4 (29) | 2 (50) | 2 (33) | 3 (33) |
| Hydroxychloroquine no. (%) | 13 (93) | 4 (100) | 6 (100) | 8 (89) |
| Corticosteroids use no. (%) | 6 (43) | 1 (25) | 4 (67) | 3 (33) |
| Remedesivir no. (%) | 4 (29) | 0 (0) | 3 (50) | 2 (22) |
| Rhabdomyolysis no. (%) | 1 (7) | 1 (25) | 1 (17) | 1 (11) |
| Cutaneous rash no. (%) | 2 (14) | 1 (25) | 1 (17) | 1 (11) |
| VTE no. (%) | 5 (36) | 2 (50) | 2 (33) | 3 (33) |
| RRT no. (%) | 5 (36) | 2 (50) | 2 (33) | 3 (33) |
| Vasopressor support no. (%) | 11 (79) | 4 (100) | 5 (83) | 7 (78) |
| Bacteremia no. (%) | 7 (50) | 3 (75) | 3 (50) | 5 (56) |
| COVID-19 diagnosis to neurological symptoms onset (days) | 35 | 37 | 33 | 35 |
| Length of hospitalization (days) | 52 | 53 | 53 | 48 |
| Length of rehabilitation (days) | 22 | 28 | 24 | 23 |
| Average peak values | ||||
| CPK (U/L) | 1958 | 2517 | 2461 | 2710 |
| D-dimer (ng/mL) | 4916 | 4820 | 6427 | 3255 |
| CRP (mg/dL) | 128 | 93 | 126 | 119 |
| ESR (mm/h) | 106 | 101 | 113 | 100 |
| Ferritin (ng/mL) | 2358 | 1875 | 2794 | 2467 |
Abbreviations: n = total cases of neuropathy in each category. ARDS: acute respiratory distress syndrome. VTE: venous thromboembolism. RRT: renal replacement therapy. CPK: creatine phosphokinase. CRP: C-reactive protein. ESR: erythrocyte sedimentation rate.